-
Sarr strikes as Palace end winless run at Brighton
-
Olympic star Ledecka says athletes ignored in debate over future of snowboard event
-
Auger-Aliassime retains Montpellier Open crown
-
Lindsey Vonn, skiing's iron lady whose Olympic dream ended in tears
-
Conservative Thai PM claims election victory
-
Kamindu fireworks rescue Sri Lanka to 163-6 against Ireland
-
UK PM's top aide quits in scandal over Mandelson links to Epstein
-
Reed continues Gulf romp with victory in Qatar
-
Conservative Thai PM heading for election victory: projections
-
Heartache for Olympic downhill champion Johnson after Vonn's crash
-
Takaichi on course for landslide win in Japan election
-
Wales coach Tandy will avoid 'knee-jerk' reaction to crushing England loss
-
Sanae Takaichi, Japan's triumphant first woman PM
-
England avoid seismic shock by beating Nepal in last-ball thriller
-
Karl defends Olympic men's parallel giant slalom crown
-
Colour and caution as banned kite-flying festival returns to Pakistan
-
England cling on to beat Nepal in last-ball thriller
-
UK foreign office to review pay-off to Epstein-linked US envoy
-
England's Arundell eager to learn from Springbok star Kolbe
-
Czech snowboard great Ledecka fails in bid for third straight Olympic gold
-
Expectation, then stunned silence as Vonn crashes out of Olympics
-
Storm-battered Portugal votes in presidential election run-off
-
Breezy Johnson wins Olympic downhill gold, Vonn crashes out
-
Vonn's Olympic dream cut short by downhill crash
-
French police arrest five over crypto-linked magistrate kidnapping
-
Late Jacks flurry propels England to 184-7 against Nepal
-
Vonn crashes out of Winter Olympics, ending medal dream
-
All-new Ioniq 3 coming in 2026
-
New Twingo e-tech is at the starting line
-
New Ypsilon and Ypsilon hf
-
The Cupra Raval will be launched in 2026
-
New id.Polo comes electric
-
Iran defies US threats to insist on right to enrich uranium
-
Seifert powers New Zealand to their record T20 World Cup chase
-
Naib's fifty lifts Afghanistan to 182-6 against New Zealand
-
Paul Thomas Anderson wins top director prize for 'One Battle After Another'
-
De Beers sale drags in diamond doldrums
-
NFL embraces fashion as league seeks new audiences
-
What's at stake for Indian agriculture in Trump's trade deal?
-
Real Madrid can wait - Siraj's dream night after late T20 call-up
-
Castle's monster night fuels Spurs, Rockets rally to beat Thunder
-
Japan votes in snow-hit snap polls as Takaichi eyes strong mandate
-
Pakistan's capital picks concrete over trees, angering residents
-
Berlin's crumbling 'Russian houses' trapped in bureaucratic limbo
-
Neglected killer: kala-azar disease surges in Kenya
-
Super Bowl set for Patriots-Seahawks showdown as politics swirl
-
Sengun shines as Rockets rally to beat NBA champion Thunder
-
Matsuyama grabs PGA Phoenix Open lead with Hisatsune one back
-
How Dental Implants Can Improve Your Quality of Life in Bonita Springs
-
Washington Post CEO out after sweeping job cuts
Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN